Sponsor or institution

Clinical trials and research at Shanghai Tongji Hospital, Tongji University School of Medicine

• 7Clinical trials
• 1Country

Newest trials

All recruiting trials (7)

• Link between tumor exosomal PRDX1 in portal-vein blood and post-surgery liver metastasis

  This study will test whether levels of exosomal PRDX1 measured in blood taken from the portal/mesenteric vein during colorectal cancer surgery can help predict who will develop liver metastases after surgery.

  Recruiting Shanghai Tongji Hospital, Tongji University School of Medicine · Shanghai, Shanghai Municipality · NCT07177742

• Multi-omics analysis of colchicine effects in acute coronary syndrome patients

  This project will try to see if daily low-dose colchicine reduces inflammation and to find biological markers that predict who benefits among people with acute coronary syndrome.

  Recruiting Shanghai Tongji Hospital, Tongji University School of Medicine · Shanghai · NCT07064109

• Evaluating a new cell therapy for B-Cell Lymphoma

  This study is testing a new cell therapy for people with hard-to-treat B-cell lymphoma to see if it is safe and effective at reducing side effects compared to traditional treatments.

  Recruiting Phase 1/2 Shanghai Tongji Hospital, Tongji University School of Medicine · Shanghai, Shanghai Municipality · NCT06987916

• CAR-NK cell therapy for lymphoma patients with primary Sjogren's syndrome

  This study is testing a new CAR-NK cell therapy to see if it can help high-risk lymphoma patients who also have primary Sjogren's syndrome feel better and reduce their lymphoma risk.

  Recruiting Phase 1/2 Shanghai Tongji Hospital, Tongji University School of Medicine · Shanghai, Shanghai Municipality · NCT06967038

• Exploring CT1190B for treating relapsed B-cell Non-Hodgkin Lymphoma

  This study is testing a new CAR-T cell therapy called CT1190B to see if it can safely help people with relapsed B-cell Non-Hodgkin Lymphoma.

  Recruiting Phase 1 Shanghai Tongji Hospital, Tongji University School of Medicine · Shanghai, Shanghai Municipality · NCT06734871

• Treatment with anti-CD19-CAR-T cells for patients with relapsed B-cell tumors

  This study is testing a new treatment using anti-CD19-CAR-T cells to see if it can help patients with relapsed B-cell tumors feel better.

  Recruiting Early Phase 1 Shanghai Tongji Hospital, Tongji University School of Medicine · Shanghai, Shanghai Municipality · NCT06375161

• Treatment using cord blood-derived CAR NK cells for relapsed B-cell lymphoma

  This study is testing a new cell therapy using cord blood to see if it can help people with relapsed B-cell lymphoma feel better and fight their cancer.

  Recruiting Phase 1/2 Shanghai Tongji Hospital, Tongji University School of Medicine · Shanghai, Shanghai Municipality · NCT05842707

Quick answers

How many clinical trials run by Shanghai Tongji Hospital, Tongji University School of Medicine are recruiting right now?

7, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in China. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1/2: 3, Early Phase 1: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →